Search - tctmd.com

Displaying 161 - 180 of 236

Sort: Relevancy | Date

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

Presenter: Tanveer Rab, Holger Thiele, Sunil V. Rao

October 14, 2015

Presentation TCT 2015

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

Presenter: Tanveer Rab, Holger Thiele, Jose P.S. Henriques

October 14, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Shock

Presenter: Tanveer Rab, Holger Thiele, Vladimir Dzavik

October 14, 2015

Presentation TCT 2015

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, William T. Abraham

October 14, 2015

Presentation TCT 2015

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

Presenter: Robert O. Bonow, Ajay J. Kirtane, David E. Kandzari

October 14, 2015

Presentation TCT 2015

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, Brij Maini

October 14, 2015

Presentation TCT 2015

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With PCI

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With Surgery

Presenter: Robert O. Bonow, Ajay J. Kirtane, Joseph F. Sabik

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient Conservatively (Medications First)

Presenter: Robert O. Bonow, Ajay J. Kirtane, Mark Goldberger

October 14, 2015

Presentation TCT 2015

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

For This Patient, I Suggest Multivessel PCI (the Freedom to Ignore FREEDOM)

Presenter: John D. Puskas, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

Presentation TCT 2015

Multivessel PCI in STEMI: Focused Commentary

Presenter: Ajay J. Kirtane, E. Magnus Ohman, Cindy L. Grines, Shamir R. Mehta

October 13, 2015

Presentation TCT 2015

Multivessel PCI in STEMI

Presenter: Ajay J. Kirtane, E. Magnus Ohman, Cindy L. Grines, Margaret B. McEntegart

October 13, 2015

News Conference News TCT 2015

FFR Guidance Remains Safe, Valuable in More Complex Disease

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

Advertisement

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

The Spectrum of Hemodynamic Support Options for Shock

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

I Would Treat This Patient With PCI

I Would Treat This Patient With Surgery

I Would Treat This Patient Conservatively (Medications First)

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

For This Patient, I Suggest Multivessel PCI (the Freedom to Ignore FREEDOM)

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Multivessel PCI in STEMI: Focused Commentary

Multivessel PCI in STEMI

FFR Guidance Remains Safe, Valuable in More Complex Disease

Discussion Highlights Merits, Limitations of Small Trials

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content